192 related articles for article (PubMed ID: 35467781)
21. Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies.
Zeraatkar D; Cooper MA; Agarwal A; Vernooij RWM; Leung G; Loniewski K; Dookie JE; Ahmed MM; Hong BY; Hong C; Hong P; Couban R; Agoritsas T; Busse JW
BMJ Open; 2022 Aug; 12(8):e054282. PubMed ID: 35926992
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Häuser W; Welsch P; Klose P; Radbruch L; Fitzcharles MA
Schmerz; 2019 Oct; 33(5):424-436. PubMed ID: 31073761
[TBL] [Abstract][Full Text] [Related]
23. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
[TBL] [Abstract][Full Text] [Related]
24. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS).
Ware MA; Wang T; Shapiro S; Collet JP;
J Pain; 2015 Dec; 16(12):1233-1242. PubMed ID: 26385201
[TBL] [Abstract][Full Text] [Related]
25. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.
Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L
Lancet Public Health; 2018 Jul; 3(7):e341-e350. PubMed ID: 29976328
[TBL] [Abstract][Full Text] [Related]
26. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
27. Mirtazapine for fibromyalgia in adults.
Welsch P; Bernardy K; Derry S; Moore RA; Häuser W
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012708. PubMed ID: 30080242
[TBL] [Abstract][Full Text] [Related]
28. Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
[TBL] [Abstract][Full Text] [Related]
29. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
[TBL] [Abstract][Full Text] [Related]
30. Long-term Cannabis-based oil therapy and pain medications prescribing patterns: an Italian observational study.
Nunnari P; Ladiana N; Ceccarelli G; Notaro P
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1224-1234. PubMed ID: 35253178
[TBL] [Abstract][Full Text] [Related]
31. [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Schaefert R; Welsch P; Klose P; Sommer C; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):47-59. PubMed ID: 25376547
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Medical Cannabis and Health-Related Quality of Life.
Arkell TR; Downey LA; Hayley AC; Roth S
JAMA Netw Open; 2023 May; 6(5):e2312522. PubMed ID: 37159196
[TBL] [Abstract][Full Text] [Related]
33. Morphine for chronic neuropathic pain in adults.
Cooper TE; Chen J; Wiffen PJ; Derry S; Carr DB; Aldington D; Cole P; Moore RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD011669. PubMed ID: 28530786
[TBL] [Abstract][Full Text] [Related]
34. Is immediate imaging important in managing low back pain?
Andersen JC
J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
[TBL] [Abstract][Full Text] [Related]
35. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly.
Abuhasira R; Schleider LB; Mechoulam R; Novack V
Eur J Intern Med; 2018 Mar; 49():44-50. PubMed ID: 29398248
[TBL] [Abstract][Full Text] [Related]
37. Herbal medicinal products or preparations for neuropathic pain.
Boyd A; Bleakley C; Hurley DA; Gill C; Hannon-Fletcher M; Bell P; McDonough S
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD010528. PubMed ID: 30938843
[TBL] [Abstract][Full Text] [Related]
38. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data.
Andreae MH; Carter GM; Shaparin N; Suslov K; Ellis RJ; Ware MA; Abrams DI; Prasad H; Wilsey B; Indyk D; Johnson M; Sacks HS
J Pain; 2015 Dec; 16(12):1221-1232. PubMed ID: 26362106
[TBL] [Abstract][Full Text] [Related]
39. Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions.
Bell AD; MacCallum C; Margolese S; Walsh Z; Wright P; Daeninck PJ; Mandarino E; Lacasse G; Kaur Deol J; de Freitas L; St Pierre M; Belle-Isle L; Gagnon M; Bevan S; Sanchez T; Arlt S; Monahan-Ellison M; O'Hara J; Boivin M; Costiniuk C
Cannabis Cannabinoid Res; 2024 Apr; 9(2):669-687. PubMed ID: 36971587
[No Abstract] [Full Text] [Related]
40. Methadone for neuropathic pain in adults.
McNicol ED; Ferguson MC; Schumann R
Cochrane Database Syst Rev; 2017 May; 5(5):CD012499. PubMed ID: 28514508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
